Select country set
Menu Shopping cart 0,00 Search
Manufactured by BioVendor

Epidermal FABP (FABP5) Human ELISA

  • Regulatory status:RUO
  • Type:Sandwich ELISA, Biotin-labelled antibody
  • Other names:FABP5, Fatty acid-binding protein epidermal, Epidermal-type fatty acid-binding protein, E-FABP, Fatty acid-binding protein 5, Psoriasis-associated fatty acid-binding protein homolog, PA-FABP
  • Species:Human
Please select your region to see available products and prices.
Cat. No. Size Price

RD191060200R 96 wells (1 kit)
PubMed Product Details
Technical Data


Sandwich ELISA, Biotin-labelled antibody


Serum, Plasma-EDTA, Plasma-Heparin, Urine

Sample Requirements

Serum, Plasma, Breast milk: 25 µl/well
Urine: 50 µl/well


At ambient temperature. Upon receipt, store the product at the temperature recommended below.


Store the complete kit at 2–8°C. Under these conditions, the kit is stable until the expiration date (see label on the box).

Calibration Curve

Calibration Range

1–40 ng/ml

Limit of Detection

0.066 ng/ml

Intra-assay (Within-Run)

n = 8; CV = 5.8 %

Inter-assay (Run-to-Run)

n = 6; CV = 6.1 %

Spiking Recovery

96.1 %

Dilution Linearity

97.9 %



  • It is intended for research use only
  • The total assay time is less than 3 hours
  • The kit measures total EFABP in serum, plasma (EDTA, heparin), urine, and breast milk
  • Assay format is 96 wells
  • Standard is a recombinant protein
  • Components of the kit are provided ready to use, concentrated or lyophilized

Research topic

Cardiovascular disease, Diabetology - Other Relevant Products, Energy metabolism and body weight regulation, Oncology


Human fatty acid binding protein EFABP is a 15 kD member of the intracellular fatty acid binding protein (FABP) family, which is known for the ability to bind fatty acids and related compounds ( bile acids or retinoids). in an internal cavity. The fatty acid binding proteins aP2 (fatty acid binding protein [FABP]-4) and mal1 (EFABP) are closely related and both are expressed in adipocytes. Absence of EFABP/mal1 resulted in increased systemic insulin sensitivity in two models of obesity and insulin resistance. Adipocytes isolated from mal1-deficient mice also exhibited enhanced insulin-stimulated glucose transport capacity. In contrast, mice expressing high levels of mal1 in adipose tissue display reduced systemic insulin sensitivity .

Product References (2)


  • Soskić V, Petrović J. Effects of several ergosines on adenylate cyclaseactivity in synaptosomal membranes of the bovine caudate nucleus. J PharmPharmacol. 1986 Feb;38(2):128-31. PubMed PMID: 2870157. See more on PubMed
  • van der Leeuw J, Beulens JW, van Dieren S, Schalkwijk CG, Glatz JF, Hofker MH,Verschuren WM, Boer JM, van der Graaf Y, Visseren FL, Peelen LM, van der SchouwYT. Novel Biomarkers to Improve the Prediction of Cardiovascular Event Risk inType 2 Diabetes Mellitus. J Am Heart Assoc. 2016 May 31;5(6). pii: e003048. doi: 10.1161/JAHA.115.003048. PubMed PMID: 27247335; PubMed Central PMCID: PMC4937255. See more on PubMed
Summary References (7)

References to Epidermal Fatty Acid Binding Protein

  • Fisher RM, Eriksson P, Hoffstedt J, Hotamisligil GS, Thorne A, Ryden M, Hamsten A, Arner P. Fatty acid binding protein expression in different adipose tissue depots from lean and obese individuals. Diabetologia. 2001 Oct;44 (10):1268-73
  • Fisher RM, Hoffstedt J, Hotamisligil GS, Thorne A, Ryden M. Effects of obesity and weight loss on the expression of proteins involved in fatty acid metabolism in human adipose tissue. Int J Obes Relat Metab Disord. 2002 Oct;26 (10):1379-85
  • Haunerland NH, Spener F. Fatty acid-binding proteins--insights from genetic manipulations. Prog Lipid Res. 2004 Jul;43 (4):328-49
  • Hertzel AV, Bennaars-Eiden A, Bernlohr DA. Increased lipolysis in transgenic animals overexpressing the epithelial fatty acid binding protein in adipose cells. J Lipid Res. 2002 Dec;43 (12):2105-11
  • Jenkins-Kruchten AE, Bennaars-Eiden A, Ross JR, Shen WJ, Kraemer FB, Bernlohr DA. Fatty acid-binding protein-hormone-sensitive lipase interaction. Fatty acid dependence on binding. J Biol Chem. 2003 Nov 28;278 (48):47636-43
  • Maeda K, Cao H, Kono K, Gorgun CZ, Furuhashi M, Uysal KT, Cao Q, Atsumi G, Malone H, Krishnan B, Minokoshi Y, Kahn BB, Parker RA, Hotamisligil GS. Adipocyte/macrophage fatty acid binding proteins control integrated metabolic responses in obesity and diabetes. Cell Metab. 2005 Feb;1 (2):107-19
  • Makowski L, Hotamisligil GS. The role of fatty acid binding proteins in metabolic syndrome and atherosclerosis. Curr Opin Lipidol. 2005 Oct;16 (5):543-8
Related Products Docs